RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 14, 2018

Total Value: $1.54B (100.0% shares, 0.0% debt)

Holdings (27)

WVE WAVE LIFE SCIENCES LTD 18.7%
Value $287M Shares 7,512,049 Share Price $38.25 * Est. Cost/Share $16.44 Unrealized @ Report Date +161.8%
ASND ASCENDIS PHARMA A S 18.3%
Value $282M Shares 4,240,536 Share Price $66.52 Est. Cost/Share $17.96 Unrealized @ Report Date —
— SOLID BIOSCIENCES INC 6.2%
Value $95.83M Shares 2,689,444 Share Price $35.63 Est. Cost/Share $7.50 Unrealized @ Report Date —
— ENDOCYTE INC 5.1%
Value $77.97M Shares 5,649,884 Share Price $13.80 Est. Cost/Share $7.70 Unrealized @ Report Date —
— MOMENTA PHARMACEUTICALS INC 4.9%
Value $75.72M Shares 3,702,533 Share Price $20.45 Est. Cost/Share $20.45 Unrealized @ Report Date —
— IMMUNOMEDICS INC 4.8%
Value $73.84M Shares 3,119,778 Share Price $23.67 Est. Cost/Share $23.67 Unrealized @ Report Date —
— MYOVANT SCIENCES LTD 4.2%
Value $64.73M Shares 2,830,455 Share Price $22.87 Est. Cost/Share $12.11 Unrealized @ Report Date —
IFRX INFLARX NV 4.1%
Value $63.44M Shares 1,967,148 Share Price $32.25 * Est. Cost/Share $20.89 Unrealized @ Report Date +65.4%
TGTX TG THERAPEUTICS INC 3.7%
Value $56.27M Shares 4,278,796 Share Price $13.15 * Est. Cost/Share $13.19 Unrealized @ Report Date +4.3%
— SAGE THERAPEUTICS INC 3.6%
Value $54.93M Shares 350,933 Share Price $156.53 Est. Cost/Share $164.71 Unrealized @ Report Date —
— ZOGENIX INC 3.3%
Value $50.62M Shares 1,145,268 Share Price $44.20 Est. Cost/Share $16.89 Unrealized @ Report Date —
RYTM RHYTHM PHARMACEUTICALS INC 3.1%
Value $48.2M Shares 1,541,743 Share Price $31.26 * Est. Cost/Share $27.34 Unrealized @ Report Date 0.0%
— DICERNA PHARMACEUTICALS INC 3.1%
Value $48.19M Shares 3,933,489 Share Price $12.25 Est. Cost/Share $18.43 Unrealized @ Report Date —
— EIDOS THERAPEUTICS INC 2.9%
Value $43.99M Shares 2,162,671 Share Price $20.34 Est. Cost/Share $20.34 Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS 2.6%
Value $40.02M Shares 6,984,692 Share Price $5.73 * Est. Cost/Share $7.39 Unrealized @ Report Date -25.5%
— RA PHARMACEUTICALS INC 2.5%
Value $38.33M Shares 3,851,808 Share Price $9.95 Est. Cost/Share $8.78 Unrealized @ Report Date —
— KALA PHARMACEUTICALS INC 1.9%
Value $29.02M Shares 2,113,236 Share Price $13.73 Est. Cost/Share $22.84 Unrealized @ Report Date —
APLS APELLIS PHARMACEUTICALS INC 1.3%
Value $19.8M Shares 900,000 Share Price $22.00 * Est. Cost/Share $14.72 Unrealized @ Report Date +56.1%
— CLEARSIDE BIOMEDICAL INC 1.1%
Value $16.3M Shares 1,525,000 Share Price $10.69 Est. Cost/Share $10.73 Unrealized @ Report Date —
— SCPHARMACEUTICALS INC 1.0%
Value $16.17M Shares 2,857,143 Share Price $5.66 Est. Cost/Share $12.09 Unrealized @ Report Date —
IOVA IOVANCE BIOTHERAPEUTICS INC 0.9%
Value $14.35M Shares 1,121,153 Share Price $12.80 * Est. Cost/Share $14.93 Unrealized @ Report Date -2.1%
KALV KALVISTA PHARMACEUTICALS INC 0.8%
Value $11.7M Shares 1,441,070 Share Price $8.12 * Est. Cost/Share $9.16 Unrealized @ Report Date -3.7%
— AVEO PHARMACEUTICALS INC 0.7%
Value $11.44M Shares 5,062,759 Share Price $2.26 Est. Cost/Share $2.59 Unrealized @ Report Date —
SPRO SPERO THERAPEUTICS INC 0.7%
Value $10.88M Shares 741,647 Share Price $14.67 * Est. Cost/Share $12.27 Unrealized @ Report Date +4.2%
— GLYCOMIMETICS INC 0.3%
Value $4.09M Shares 253,547 Share Price $16.13 Est. Cost/Share $16.23 Unrealized @ Report Date —
— PROTEON THERAPEUTICS INC 0.2%
Value $3.277M Shares 1,337,462 Share Price $2.45 Est. Cost/Share $1.53 Unrealized @ Report Date —
— G1 THERAPEUTICS INC 0.1%
Value $1.738M Shares 40,000 Share Price $43.45 Est. Cost/Share $17.44 Unrealized @ Report Date —